Diaceutics (DXRX)

Sector:

Health Care

Index:

FTSE AIM All-Share

 137.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 150.00
  • 52 Week Low: 108.00
  • Currency: UK Pounds
  • Shares Issued: 84.77m
  • Volume: 73,607
  • Market Cap: £116.56m
  • RiskGrade: 196
  • Beta: 0.00

News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Diaceutics Market Data

Currency UK Pounds
Share Price 137.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 150.00
52 Week Low 108.00
Volume 73,607
Shares Issued 84.77m
Market Cap £116.56m
Beta 0.00
RiskGrade 196

Diaceutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
33.38% below the market average33.38% below the market average33.38% below the market average33.38% below the market average33.38% below the market average
57.58% below the sector average57.58% below the sector average57.58% below the sector average57.58% below the sector average57.58% below the sector average
Price Trend
71.59% above the market average71.59% above the market average71.59% above the market average71.59% above the market average71.59% above the market average
83.78% above the sector average83.78% above the sector average83.78% above the sector average83.78% above the sector average83.78% above the sector average
Income Not Available
Growth
41.02% above the market average41.02% above the market average41.02% above the market average41.02% above the market average41.02% above the market average
54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average

Diaceutics Dividends

No dividends found

Trades for 30-May-2025

Time Volume / Share Price
15:41 36 @ 135.00p
15:41 134 @ 140.00p
15:41 1 @ 140.00p
15:28 15,000 @ 120.00p
11:51 361 @ 138.50p

Diaceutics Key Personnel

CEO Ryan Gerard Keeling
CFO Nick Roberts

Top of Page